» Articles » PMID: 24488489

Is There an Optimal Dose for Dietary Linoleic Acid? Lessons from Essential Fatty Acid Deficiency Supplementation and Adipocyte Functions in Rats

Overview
Specialties Biochemistry
Physiology
Date 2014 Feb 4
PMID 24488489
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Differential effects of n-3 and n-6 polyunsaturated fatty acids (PUFAs) have been demonstrated on adipose tissue physiology. Facing to the widely recognized beneficial effects of n-3 PUFAs, the n-6 PUFA effects remain controversial. Thus, we further analyzed the linoleic acid (LA) influence on adipocyte functions. To this aim, we treated by LA supplementation at three distinct doses (1, 2.5, or 5% of energy intake) rats with essential fatty acids deficiency (EFAD). PUFA composition was determined in blood and white adipose tissue (WAT), while lipolytic and lipogenic activities were measured in isolated adipocytes. EFAD rats exhibited reduced WAT mass and increased EFAD biomarkers. WAT mass was completely recovered after supplementation, irrespective of LA dose. However, neither body mass nor EFAD biomarkers returned to control with 1% LA, while LA abundance doubled in adipocytes from rats supplemented with 5% LA. Regarding lipolysis, 2.5% LA normalized the EFAD-induced alterations. A trend to decrease the maximal stimulation of lipolysis was observed with 1 and 5% LA. Regarding lipogenesis, the lower and higher LA doses increased basal activity and hampered insulin to further stimulate glucose incorporation into lipids whereas 2.5% LA normalized the basal or insulin-stimulated levels. Our results show that dietary linoleate at 2.5% restored anatomical, biochemical, and functional disturbances induced by EFAD. At higher dose, LA tended to reduce triacylglycerol breakdown, to increase triacylglycerol assembly, and to provoke insulin resistance. Therefore, LA influence on adipocyte functions does not appear to follow a typical dose-response relationship, adding further complexity to the definition of its dietary requirement.

Citing Articles

The anxiolytic drug opipramol inhibits insulin-induced lipogenesis in fat cells and insulin secretion in pancreatic islets.

Iglesias-Osma M, Garcia-Barrado M, Hernandez-Gonzalez D, Perrier K, Viana P, Carpene C J Physiol Biochem. 2023; 79(2):415-425.

PMID: 36821072 DOI: 10.1007/s13105-023-00950-8.


High doses of tyramine stimulate glucose transport in human fat cells.

Carpene C, Les F, Mercader-Barcelo J, Boulet N, Briot A, Grolleau J J Physiol Biochem. 2022; 78(2):543-556.

PMID: 35066863 DOI: 10.1007/s13105-021-00864-3.


Novel Facet of an Old Dietary Molecule? Direct Influence of Caffeine on Glucose and Biogenic Amine Handling by Human Adipocytes.

Ahmed W, Boulet N, Briot A, Ryan B, Kinsella G, OSullivan J Molecules. 2021; 26(13).

PMID: 34201708 PMC: 8270301. DOI: 10.3390/molecules26133831.


Variations in adrenal gland medulla and dopamine effects induced by the lack of Irs2.

Catalano-Iniesta L, Iglesias-Osma M, Sanchez-Robledo V, Carretero-Hernandez M, Blanco E, Carretero J J Physiol Biochem. 2018; 74(4):667-677.

PMID: 30367392 DOI: 10.1007/s13105-018-0655-8.


Body fat reduction without cardiovascular changes in mice after oral treatment with the MAO inhibitor phenelzine.

Carpene C, Mercader J, Le Gonidec S, Schaak S, Mialet-Perez J, Zakaroff-Girard A Br J Pharmacol. 2018; 175(12):2428-2440.

PMID: 29582416 PMC: 5980542. DOI: 10.1111/bph.14211.


References
1.
Juaneda P, Rocquelin G . Rapid and convenient separation of phospholipids and non phosphorus lipids from rat heart using silica cartridges. Lipids. 1985; 20(1):40-1. DOI: 10.1007/BF02534360. View

2.
Simopoulos A . Is insulin resistance influenced by dietary linoleic acid and trans fatty acids?. Free Radic Biol Med. 1994; 17(4):367-72. DOI: 10.1016/0891-5849(94)90023-x. View

3.
Eder E, Wacker M, Lutz U, Nair J, Fang X, Bartsch H . Oxidative stress related DNA adducts in the liver of female rats fed with sunflower-, rapeseed-, olive- or coconut oil supplemented diets. Chem Biol Interact. 2005; 159(2):81-9. DOI: 10.1016/j.cbi.2005.09.004. View

4.
Ailhaud G, Massiera F, Weill P, Legrand P, Alessandri J, Guesnet P . Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res. 2006; 45(3):203-36. DOI: 10.1016/j.plipres.2006.01.003. View

5.
Hellwig B, Brown F, Schurmann A, Shanahan M, Joost H . Localization of the binding domain of the inhibitory ligand forskolin in the glucose transporter GLUT-4 by photolabeling, proteolytic cleavage and a site-specific antiserum. Biochim Biophys Acta. 1992; 1111(2):178-84. DOI: 10.1016/0005-2736(92)90309-a. View